Respirix
Non-invasive Hemodynamic Monitoring
Overview
Raised: $1,300,226
Platform
SeedInvest
Start Date
11/23/2018
Close Date
08/13/2019
Min. Goal
$200
Max. Goal
$1,500,000
Min. Investment
$200
Security Type
Debt
SEC Filing Type
RegD 506(c)
Status
Funded
Reporting Date
08/30/2019
Days Remaining
Funded
% of Min. Goal
Funded
% of Max. Goal
Funded
Likelihood of Max
Funded
Avg. Daily Raise
$4,963
Momentum
Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded
2015
Industry
Healthcare & Pharmaceuticals
Tech Sector
HealthTech
Location
San Francisco, California
Respirix is raising funds on SeedInvest through Reg D 506(c) raise. The company has developed a handheld and portable device for non-invasive monitoring of congestive heart failure (CHF) patients. The device, Cardiospire, acquires and analyses a subtle pressure wave called a cariogenic oscillation for low-cost and non-invasive patient care management. The algorithm then ascertains if the patient is approaching CHF even before they experience symptoms. Daniel Burnett and Evan Luxon founded Respirix in 2015. The current crowdfunding campaign has a maximum target of $1.5 million. The campaign proceeds will be used for growth and expansion.
Create a free account today to gain access to KingsCrowd analytics.
Upgrade to gain access
Pay Monthly
Annually (Save 17%)
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Already a member? Log in here.
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.